UMIT TIROL – Private University for Health Sciences and Technology is an accredited private university owned by the Province of Tyrol and the Leopold-Franzens-University Innsbruck with its headquarters in Hall in Tirol, Austria. UMIT TIROL is an internationally recognized university with a focus on Health Sciences, Life Sciences und Health Care Technologies.
The Institute of Public Health, Medical Decision Making and Health Technology Assessment (Head: Univ.-Prof. Dr. Uwe Siebert) of the Department of Public Health, Health Services Research and Health Technology Assessment is currently seeking to appoint a:
to commence as soon as possible and initially limited to three years in full-time or part-time (100%, 75% or 50%); an extension is possible and is being sought.
The position is affiliated with the MeDeMSA and EUCanScreen projects, as well as other research initiatives in health decision science.
The Medical Decision Making in MSA (MeDeMSA) Research Group aims to develop personalized diagnostic and therapeutic strategies for individuals living with multiple system atrophy (MSA). Its overarching goals are to enable early and accurate diagnosis to support clinical trial recruitment, and to improve quality of life for patients and caregivers—while addressing ethical, legal, and health-economic considerations. The PhD research will focus on systematic decision analysis and health technology assessment (HTA) in MSA, including statistical analysis, benefit-harm evaluations, cost-effectiveness analyses, and equity assessments to support decision-making by patients, providers, and payers.
The EUCanScreen project aims to ensure the sustainable implementation of high-quality screening programs for breast, cervical, and colorectal cancer, and to prepare for implementing recently recommended screenings for lung, prostate, and gastric cancers. At UMIT TIROL, subprojects emphasize the full implementation of evidence-based, cost-effective, and quality-assured screening programs—particularly for breast, cervical, and colorectal cancers—with a focus on expanding to lung and prostate cancer screening.
The salary is based on the salary group scheme of UMIT TIROL and amounts to € 2.786,10 (full-time).
UMIT TIROL values diversity and therefore welcomes all applications – regardless of gender, nationality, ethnic and social origin, religion, world view, disability, age, sexual orientation and identity. The university is also committed to promoting women in science and therefore expressly encourages qualified women to apply.
Please submit your application with the usual documents (letter of motivation, curriculum vitae, credentials, certificates, references) until May 31, 2025 exclusively in electronic form https://bewerbermanagement.net/4d35f
For further information please contact Assoc.-Prof. Dr. Beate Jahn (public-health@umit-tirol.at, phone: +43-50-8648-3930).
UMIT TIROL – Private Universität für Gesundheitswissenschaften und -technologie GmbH, Eduard-Wallnöfer-Zentrum 1,
6060 Hall in Tirol, Österreich, T +43-50-8648-3000
Informationen zum Datenschutz finden Sie unter www.umit-tirol/datenschutz